The Effort to Rationalize Antibiotic Use in Indonesian Hospitals: Practice and Its Implication.


Journal

Journal of tropical medicine
ISSN: 1687-9686
Titre abrégé: J Trop Med
Pays: Egypt
ID NLM: 101524194

Informations de publication

Date de publication:
2023
Historique:
received: 20 06 2022
revised: 12 01 2023
accepted: 21 01 2023
entrez: 7 3 2023
pubmed: 8 3 2023
medline: 8 3 2023
Statut: epublish

Résumé

An effective strategy for combatting AMR in Indonesia is to make the use of antibiotics in hospitals more rational with the help of an Antimicrobial Resistance Control Program (AMR-CP). This study aims to analyze the implementation of the AMR-CP in hospitals by conducting in-depth interviews with health professionals from ten hospitals and health officers of ten provincial health offices in ten different provinces and observation towards its documents. The sample location was selected by purposive sampling. Informants at the hospitals were hospital directors, chairmen of the AMR-CP team, chairmen of the medical committee, persons in charge of the microbiology laboratory, clinicians, nurses, clinical pharmacists, and those program managers at the provincial health offices who are responsible for administering antibiotics. Information is first collected and then a thematic analysis is applied along with triangulation to confirm the validity of information from multiple sources, including document observation results. The analysis is adapted to the framework of the system (i.e., input, process, and output). Results show that hospitals in Indonesia already have the resources to implement AMR-CP, including AMR-CP team and microbiology laboratories. Six hospitals examined also have clinicians trained in microbiology. Though hospital leadership and its commitment to implementing AMR-CP are favorable, there is room for improvement. AMR-CP teams organize routine activities for socialization and training, develop standard operating procedures (SOPs) for antibiotic use, antibiotic patterns surveillance, and bacterial mapping. Some obstacles to implementing AMR-CP policies are posed by the human resources, facilities, budget, antibiotics and reagent shortages, and clinician compliance with SOPs. The study concludes that there was an improvement in antibiotic sensitivity patterns, rational use of antibiotics, use of microbiological laboratories, and cost-efficiency. It recommends the government and healthcare providers continue to improve AMR-CP in hospitals and promote AMR-CP policy by making the regional health office of the hospital a representative of the regional government.

Identifiants

pubmed: 36879892
doi: 10.1155/2023/7701712
pmc: PMC9985506
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7701712

Informations de copyright

Copyright © 2023 Selma Siahaan et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Front Public Health. 2022 Mar 16;10:790892
pubmed: 35372208
J Glob Antimicrob Resist. 2015 Dec;3(4):290-294
pubmed: 27842876
J Glob Antimicrob Resist. 2022 Mar;28:115-119
pubmed: 34933139
BMC Pharmacol Toxicol. 2014 Feb 26;15:8
pubmed: 24568120
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S135-S141
pubmed: 30423041
Antimicrob Resist Infect Control. 2017 May 15;6:47
pubmed: 28515903
Jt Comm Perspect. 2016 Jul;36(7):1, 3-4, 8
pubmed: 27548932
J Trop Med. 2015;2015:261925
pubmed: 25838829
J Infect Public Health. 2018 Jan - Feb;11(1):30-34
pubmed: 28285971
J Trop Med. 2022 Feb 7;2022:2783300
pubmed: 35145554
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
J Glob Antimicrob Resist. 2022 Jun;29:74-87
pubmed: 35158078
Antimicrob Resist Infect Control. 2018 Sep 10;7:109
pubmed: 30214718
Euro Surveill. 2013 Jan 10;18(2):
pubmed: 23324427
J Infect Public Health. 2020 Dec;13(12):2087-2091
pubmed: 31164316
Biomed Res Int. 2015;2015:214021
pubmed: 25945327
JAC Antimicrob Resist. 2021 Apr 26;3(2):dlab047
pubmed: 33937773
Interdiscip Perspect Infect Dis. 2022 Apr 12;2022:8140429
pubmed: 35464254
Antibiotics (Basel). 2022 Jun 01;11(6):
pubmed: 35740161
J Glob Antimicrob Resist. 2022 Jun;29:155-162
pubmed: 35283333
P T. 2015 Apr;40(4):277-83
pubmed: 25859123
J Glob Antimicrob Resist. 2022 Jun;29:259-274
pubmed: 35342021
BMJ Open. 2020 Mar 31;10(3):e030823
pubmed: 32234736
Int J Mol Sci. 2019 Mar 27;20(7):
pubmed: 30934725

Auteurs

Selma Siahaan (S)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Rukmini Rukmini (R)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Betty Roosihermiatie (B)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Pramita Andarwati (P)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Rini S Handayani (RS)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Ingan U Tarigan (IU)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Tita Rosita (T)

Centre for Health Financing and Decentralization Policy, Ministry of Health-Indonesia, Jakarta, Indonesia.

Rustika Rustika (R)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Yuslely Usman (Y)

Centre for Health Financing and Decentralization Policy, Ministry of Health-Indonesia, Jakarta, Indonesia.

Lusi Kristiana (L)

Organization Research for Health, The National Research and Innovation Agency-Indonesia, Jakarta, Indonesia.

Classifications MeSH